| 1 | AXSM | Axsome Therapeutics, Inc. | 4.73% |
| 2 | PRAX | Praxis Precision Medicines, Inc. | 4.52% |
| 3 | BIIB | Biogen Inc. | 4.14% |
| 4 | PTCT | PTC Therapeutics, Inc. | 4.08% |
| 5 | ACAD | ACADIA Pharmaceuticals Inc. | 4.03% |
| 6 | ALKS | Alkermes plc | 4.01% |
| 7 | SRRK | Scholar Rock Holding Corporation | 3.77% |
| 8 | XENE | Xenon Pharmaceuticals Inc. | 3.74% |
| 9 | ARGX | argenx SE | 3.66% |
| 10 | SUPN | Supernus Pharmaceuticals, Inc. | 3.65% |
| 11 | NBIX | Neurocrine Biosciences, Inc. | 3.63% |
| 12 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.40% |
| 13 | KRX: 326030 | SK Biopharmaceuticals Co., Ltd. | 3.32% |
| 14 | DNLI | Denali Therapeutics Inc. | 3.04% |
| 15 | SRPT | Sarepta Therapeutics, Inc. | 3.00% |
| 16 | CNTA | Centessa Pharmaceuticals plc | 2.96% |
| 17 | AVDL | Avadel Pharmaceuticals plc | 2.73% |
| 18 | DYN | Dyne Therapeutics, Inc. | 2.59% |
| 19 | HLUNB.CO | H. LUNDBECK CLASS B | 2.44% |
| 20 | EWTX | Edgewise Therapeutics, Inc. | 2.38% |
| 21 | AXGN | Axogen, Inc. | 1.90% |
| 22 | ASX: NEU | Neuren Pharmaceuticals Limited | 1.86% |
| 23 | STO: BIOA.B | BioArctic AB (publ) | 1.77% |
| 24 | DNTH | Dianthus Therapeutics, Inc. | 1.73% |
| 25 | TSHA | Taysha Gene Therapies, Inc. | 1.60% |
| View IBRN holdings |
